联环药业(600513.SH)：原料药产品左炔诺孕酮通过世界卫生组织预认证

Core Viewpoint - The company, Lianhuan Pharmaceutical (600513.SH), has received notification from the World Health Organization (WHO) that its active pharmaceutical ingredient, Levonorgestrel (APIMF484, WHO API-484), has passed the WHO prequalification (PQ) process and is now included in the procurement scope of international organizations and public institutions [1] Group 1 - The product has successfully passed the WHO prequalification site inspection [1] - As of the date of this announcement, the Drug Master File (DMF) review for the product has also been completed [1] - The product is now fully prequalified by the WHO [1]